SCHEMBL7104912

SCHEMBL7104912

CCOC(=O)c1cc(CC)c2c(C)c(Cl)ccn2c1=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 10/20 0.51
ALDH1A1 P00352 7/20 0.51
HPGD P15428 4/20 0.51
GLA P06280 3/20 0.51
GAA P10253 3/20 0.51
BAZ2B Q9UIF8 1/20 0.45
BAZ2A Q9UIF9 1/20 0.45
PDE3B Q13370 3/20 0.43
PDE3A Q14432 3/20 0.43
NPSR1 Q6W5P4 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
MAPK1 P28482 1/20 0.42
CYP4F2 P78329 1/20 0.42
CYP4A11 Q02928 1/20 0.42
KMT2A Q03164 1/20 0.42
RECQL P46063 1/20 0.41
HSD17B10 Q99714 1/20 0.41
MAPT P10636 1/20 0.40
TSHR P16473 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7099748 0.86 KDM4E (0.48) KDM4EALDH1A1HPGDGLAGAA
SCHEMBL1289966 0.83 KDM4E (0.46) KDM4EALDH1A1HPGDGLAGAA
SCHEMBL8130968 0.80 KDM4E (0.57) KDM4EALDH1A1HPGDGLAGAA
SCHEMBL5422492 0.74 KDM4E (0.43) KDM4EALDH1A1HPGDGLAGAA
SCHEMBL6755336 0.71 KDM4E (0.50) KDM4EALDH1A1HPGDGLAGAA
SCHEMBL8024526 0.71 KDM4E (0.74) KDM4EALDH1A1HPGDGLAGAA
SCHEMBL4626645 0.71 CYP4F2 (0.51) KDM4EALDH1A1GAABAZ2BBAZ2A
SCHEMBL22641593 0.71 ALDH1A1 (0.33) KDM4EALDH1A1HPGDGLAGAA
SCHEMBL8643589 0.71 KDM4E (0.40) KDM4EALDH1A1HPGDGLAGAA
SCHEMBL1290296 0.71 HSP90AA1 (0.38) KDM4EALDH1A1HPGDGLANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030171587-A1 Antimicrobial 2-pyridones, their compositions and uses THE PROCTER & GAMBLE COMPANY 2003-09-11 US disclosed
EP-1341787-A2 ANTIMICROBIAL 2-PYRIDONES, THEIR COMPOSITIONS AND USES The Procter & Gamble Company (US) 2003-09-10 EP disclosed
US-6509349-B1 suppressing the growth or reproduction of microorganisms, such as bacteria. For example, such antibacterials and other antimicrobials are described in Antibiotics, Chemotherapeutics, and Antibacterial Agents for Disease THE PROCTER & GAMBLE COMPANY 2003-01-21 US disclosed
WO-2002048143-A2 ANTIMICROBIAL 2-PYRIDONES, THEIR COMPOSITIONS AND USES THE PROCTER & GAMBLE COMPANY (US) 2002-06-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030171587-A1 Antimicrobial 2-pyridones, their compositions and uses PIR, PRDX6, CLPP KDM4E 4436/4885ALDH1A1 3730/4885HPGD 1591/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.